drugset / Trial / NCT00471341

Effect of Celecoxib on Markers of Vascular Inflammation

NCT00471341

Phase 4 Completed 75 enrolled University of Florida Pfizer · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This study involves a drug called celecoxib, which is commonly prescribed for people with arthritis. Arthritis is caused by inflammation of the joints or tissues. Inflammation also occurs in the blood vessels that lead to your heart, and the purpose of this study is to see if celecoxib can reduce the blood vessel inflammation associated with high cholesterol and heart disease.

Timeline

Start
2002-07
Primary completion
Completion
2004-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified